• Publications
  • Influence
Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms.
The widely cited mean prevalence of PPD-10-15% is not representative of the actual global prevalence and magnitude of the problem, due to the wide range of reports. Expand
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
It is demonstrated here that the burden of PMS/PMDD as well as the disability adjusted life years lost due to this repeated-cyclic disorder is in the same magnitude as major recognized disorders. Expand
The etiology, biology, and evolving pathology of premenstrual syndromes
  • U. Halbreich
  • Medicine, Biology
  • Psychoneuroendocrinology
  • 1 August 2003
Direct directions for clinically-relevant progress include identification of specific subgroups of menstrually-related syndromes, assessment of the genetic vulnerability and changes in vulnerability along the life cycle, the diversified mechanisms by which vulnerability is translated into pathophysiology and symptoms, the normalization process as well as syndrome-based and etiology-based clinical trials. Expand
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus
An international multidisciplinary group of experts met at a face-to-face consensus meeting to review current definitions and diagnostic criteria for PMD to provide a unified approach for the diagnostic criteria, their quantification and guidelines on clinical trial design. Expand
Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.
An imbalance between the pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines (INF-gamma or TNF-alpha and IL-4) occurred in untreated depressed patients, suggesting that a major imbalance in inflammatory response and an imbalance between T-helper 1 and 2 functions occurred. Expand
Premenstrual changes: patterns and correlates of daily ratings.
Daily ratings of 20 measures of mood, behavior, and physical condition made by 64 women for one menstrual cycle were analysed and five discriminantly different dimensions of premenstrual change were identified. Expand
Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone 1 1 This work was sponsored by Eli Lilly and Company.
Hyperprolactinemia is very prevalent among women and men treated with conventional antipsychotic medications or risperidone and should be seriously considered when choosing an antipsychotics suitable for the patient. Expand
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Pharmacotherapy provides considerable relief from the symptoms of dysthymia in patients suffering from this chronic affective disorder, with both sertraline and imipramine being more effective than placebo. Expand
Premenstrual Daily Fluoxetine for Premenstrual Dysphoric Disorder: A Placebo‐Controlled, Clinical Trial Using Computerized Diaries
Premenstrual daily dosing with fluoxetine effectively treats mood, physical, and social functioning symptoms associated with premenstrual dysphoric disorder. Expand
Effectiveness of St John's wort in major depression: a randomized controlled trial.
St John's wort was not effective for treatment of major depression and the number reaching remission of illness was significantly higher with St John’s wort than with placebo. Expand